164 related articles for article (PubMed ID: 2239487)
1. Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
Lees AJ
Adv Neurol; 1990; 53():475-82. PubMed ID: 2239487
[No Abstract] [Full Text] [Related]
2. Madopar HBS in nocturnal symptoms of Parkinson's disease.
Jansen EN; Meerwaldtt JD
Adv Neurol; 1990; 53():527-31. PubMed ID: 2239493
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
[TBL] [Abstract][Full Text] [Related]
4. Treatment of early Parkinson's disease with controlled-release levodopa preparations.
Rinne UK; Rinne JO
Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766
[TBL] [Abstract][Full Text] [Related]
5. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Zimmerman TR; Sage JI; Lang AE; Mark MH
Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group.
Clin Neuropharmacol; 1989 Dec; 12(6):498-505. PubMed ID: 2691069
[TBL] [Abstract][Full Text] [Related]
7. Open study of sustained-release formulation of levodopa and benserazide in parkinsonian patients.
Kostić VS; Covicković-Sternić N
Neurologija; 1990; 39(2):99-105. PubMed ID: 2267052
[TBL] [Abstract][Full Text] [Related]
8. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
Dessibourg CA; Gachoud JP
Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with Madopar HBS in parkinsonians with fluctuations.
Chouza C; Aljanati R; Caamaño JL; De Medina O; Scaramelli A; Buzó R; Plachín V; Fernandez A; Romero S
Adv Neurol; 1990; 53():519-26. PubMed ID: 2122654
[TBL] [Abstract][Full Text] [Related]
10. Madopar HBS in fluctuating parkinsonian patients: two-year treatment.
Pezzoli G; Tesei S; Ferrante C; Cossutta E; Zecchinelli A; Scarlato G
Mov Disord; 1988; 3(1):37-45. PubMed ID: 3050471
[TBL] [Abstract][Full Text] [Related]
11. Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
Marion MH; Stocchi F; Quinn NP; Jenner P; Marsden CD
Adv Neurol; 1987; 45():493-6. PubMed ID: 3548262
[No Abstract] [Full Text] [Related]
12. Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients.
Dupont E; Andersen A; Boas J; Boisen E; Borgmann R; Helgetveit AC; Kjaer MO; Kristensen TN; Mikkelsen B; Pakkenberg H; Presthus J; Stien R; Worm-Petersen J; Buch D
Acta Neurol Scand; 1996 Jan; 93(1):14-20. PubMed ID: 8825266
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease.
MacMahon DG; Sachdev D; Boddie HG; Ellis CJ; Kendal BR; Blackburn NA
J Neurol Neurosurg Psychiatry; 1990 Mar; 53(3):220-3. PubMed ID: 2182781
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
Poewe WH; Lees AJ; Stern GM
Eur Neurol; 1987; 27 Suppl 1():93-7. PubMed ID: 3322842
[TBL] [Abstract][Full Text] [Related]
15. [Efficiency of new forms of madopar in Parkinson's disease].
Vendrova MI; Sadekov RA; Golubev VL
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
[TBL] [Abstract][Full Text] [Related]
16. Madopar HBS in Parkinson patients with nocturnal akinesia.
Jansen EN; Meerwaldt JD
Clin Neurol Neurosurg; 1988; 90(1):35-9. PubMed ID: 3359732
[TBL] [Abstract][Full Text] [Related]
17. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
[TBL] [Abstract][Full Text] [Related]
18. Treating motor fluctuations with controlled-release levodopa preparations.
Koller WC; Pahwa R
Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC
Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646
[No Abstract] [Full Text] [Related]
20. Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
Marion MH; Stocchi F; Malcolm SL; Quinn NP; Jenner P; Marsden CD
Eur Neurol; 1987; 27 Suppl 1():54-8. PubMed ID: 3322837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
